JTEKT Targets 100% Capacity Utilization in 1.5 Years

JTEKT India Limited — Q4 FY26 Earnings Call (FY ended 31 Mar 2026; call held 20 May 2026)

1. Overall Tone of Management: Optimistic

• Management repeatedly frames results as “improvement” and “temporary factors,” and emphasizes upcoming SOP/ramp-ups and new orders (e.g., “temporary” margin headwinds; “we expect” exports and model launches to improve).
• Strong confidence in capacity utilization and growth levers: “we expect that our capacity will be 100% utilized within 1.5 years” and “we are very hopeful” on CVJ/Brazil/Honda recovery.

2. Key Themes from Management Commentary

• Demand uplift from GST reform (Sep 2025): GST cut improved affordability; management links it to stronger 2H FY26 growth in passenger vehicles and specific Maruti models (Alto, Jimny, Baleno, Ertiga, Brezza).
• Sales outperformance vs market: FY26 JTEKT sales grew 11% vs passenger vehicle market 9%.
• Margin improvement but not full recovery: EBITDA margin improved in 2H to 8.48% (from 7.71% prior year), yet full-year EBITDA margin declined slightly (management cites 7.5% vs 7.6%).
• Cost control narrative: “strict control of fixed costs” (employee/admin savings as % of sales), but variable costs rose due to mix, power tariffs, export reciprocal tariff, and accounting effects.
• Export and global expansion via group entities:
• Brazil order (Stellantis platform) starting dispatch from May 2026, with expectation of scaling volumes.
• Management positions India as a “global site” for JTEKT group supply chain.
• Capacity ramp as the core growth engine:
• Multiple SOPs already underway/coming (Maruti EV Gujarat MPV EV; CVJ third line; MS Gear/CPS lines; Gujarat plant).
• Repeated emphasis that underutilization is temporary and should normalize with SOP timing.

3. Q&A Analysis

Theme A: Gross margin / EBITDA margin drivers and outlook

• Core questions
• Why gross margins declined over time (29% → 27% trend) and what to expect going forward.
• Management response
• Explained margin movement via fixed vs variable cost and detailed variable-cost bridge:
  • Fixed cost improved (employee/admin savings; rights issue expense included in admin).
  • Variable cost increased due to:
  • Product mix change (declines in Honda/exports; higher Maruti models with slightly lower margins).
  • FX accounting impact on imports (described as accounting practice causing “negative” impact).
  • Power tariff / trial line power usage (one-time).
  • Selling cost: warranty down (positive) offset by US reciprocal tariff (negative).
• Framed these as temporary and expected to ease with SOP completion and tariff changes.
• Notable / evasive / strong points
• Strongly “temporary” framing, but some explanations are accounting-driven (FX treatment) and mix-driven, which may recur depending on customer mix.
• Management explicitly says they “should not be getting hit by the same kind of drastic product mix change next year,” but provides limited evidence beyond expectations.

Theme B: Toyota capacity / Bidadi plant timing and revenue mix

• Core questions
• Confirm whether Toyota’s Bidadi third line has commenced; implications for Toyota revenue share.
• Follow-up on whether JTEKT Corp plans to expand beyond CVJ/Hub unit bearings into other driveline products.
• Management response
• Toyota Bidadi third line: not commenced; new facility expected first half of ’29 (capacity +1 lakh vehicles).
• Toyota revenue share: management stated Toyota share 10% this year vs 12% last year; also attributed changes to Maruti share shift.
• On product expansion: aspiration to grow driveline portfolio, but “takes time” and they want to stabilize CVJ first; no concrete near-term plan for other driveline SKUs.
• Notable
• Clear correction of timing (analyst believed it started; management said it hasn’t), which is a credibility datapoint.

Theme C: Revenue ramp / incremental revenue from new capacities; ROCE

• Core questions
• Update on prior revenue guidance (adding ~INR 1,000 cr by F27) and whether revenue could double in 3–4 years.
• How much incremental revenue once current capacity is fully utilized.
• ROCE trajectory given ROCE decline (16% → ~10%) and CWIP impact.
• Capex guidance for FY27.
• Management response
• Incremental revenue logic: already delivered ~INR 300 cr increase this year; next year “conservative INR ~800 cr additional” based on market growth assumptions and export add-ons.
• Declined to give a firm next-year business plan: “We don’t share that.”
• ROCE: attributed decline to CWIP; management said removing CWIP improves ROCE to >11% and expects ROCE to return as utilization and profits rise.
• Capex FY27: Gujarat plant spend ongoing; committed ~INR 250 cr total for the unit, with “another ~INR100 cr” plus “normal capex,” and not as huge as last 2 years.
• Notable / evasive
• Revenue-doubling question answered with scenario-based language rather than commitment.
• Strong emphasis on CWIP as the ratio distortion—helpful, but also a common way to defer performance accountability until utilization.

Theme D: CVJ strategy, pipeline products, margins vs consolidated, and backward integration

• Core questions
• Other driveline products in near-term pipeline beyond CVJ.
• CVJ margins vs consolidated; fixed asset turnover / FATR assumptions.
• Clarify CWIP usage and what lines it supports.
• Management response
• CVJ: target 15% market share; third line and Gujarat expansion to support ramp; “give us time” before moving to other products.
• CVJ margins: stated better than manual gear; “EBITDA margins are better” and CVJ is “100% localized.”
• FATR: product-dependent; target “upward of 3x” once utilized; CVJ may be lower (1.5x) but still profitable.
• CWIP: acknowledged as affecting ratios; did not provide a full line-by-line CWIP allocation in this call (time constraints).
• Notable
• Management provides a quantified CVJ capacity utilization narrative (line 2 at 27% utilized, line 1 at 83%, etc.), which is more concrete than prior calls’ generalities.

Theme E: Brazil order scaling and global expansion

• Core questions
• Whether discussions exist with other JTEKT entities; future plan to cater to other group entities.
• Potential for exports to US/Europe; strategy given global losses at JTEKT Corp.
• Management response
• Brazil: first shipment May 2026; expected ~70,000 units in current year, scaling to ~100k–150k next year, and “up to 5 lakh units over time.”
• Other entities: yes—Brazil is framed as proof-of-capability; “more business waiting” if they perform on quality/cost/on-time.
• US/Europe: “moving in that direction,” starting with Brazil; wait for additional orders after demonstrating competitiveness.
• Notable
• Strong “proof-of-supplier” logic, but still no binding commitments on US/Europe volumes.

4. Guidance / Outlook

Explicit guidance (quantitative)

• Passenger vehicle growth / demand linkage (qualitative-to-quant):
• No formal company-wide revenue guidance, but management provides capacity utilization expectations:
  • “capacity will be 100% utilized within 1.5 years”
  • CVJ line ramp expectations tied to SOP timing (e.g., 2 CVJ lines to reach ~90% utilization after Maruti MPV EV SOP).
• Brazil order volumes:
• Current year: ~70,000 units
• Next year: ~100,000 to 150,000 units
• Longer term: “up to 5 lakh units per annum” (over time)
• Capex FY27:
• Gujarat plant: “another ~INR100 cr” after already spent/committed; plus “normal capex”
• CVJ market share target:
• “touch about 15% market share” (aspirational target)

Implicit signals (qualitative)

• Margin: management expects gross/EBITDA pressure to ease as:
• “temporary factors” (FX accounting, product mix, trial power, US tariff impact) normalize.
• Growth: management implies revenue upside is primarily a function of:
• SOP delays clearing,
• capacity utilization rising,
• exports scaling (Brazil + improved US + potential Honda recovery).

5. Standout Statements (directly revealing)

• On margin headwinds being temporary:
• “These factors… are temporary, and we should not be getting hit by the same kind of a drastic product mix change next year.”
• On capacity utilization certainty:
• “we expect that our capacity will be 100% utilized within 1.5 years”
• On ROCE distortion from CWIP:
• “Our CWIP… is about INR411 crores. So… if I simply remove it… return on capital employed improves to more than 11%.”
• On Brazil ramp:
• “first shipment… May…” and “about 70,000 units” in current year; “100,000 to 150,000” next year.
• On Toyota Bidadi timing correction:
• “No… that has not already commenced. … first half of ’29.”
• On CVJ localization and margin quality:
• “CVJ is one product, where we have almost 100% localization… EBITDA margins are better…”

6. Red Flags / Positive Signals

Red flags
– “Temporary” margin explanations rely on mix and accounting effects; these can recur if customer mix doesn’t revert.
– Limited commitment on revenue guidance: repeated refusal to share next-year business plan (“We don’t share that”).
– Capacity utilization confidence is high, but SOP timing has historically slipped (e.g., Maruti SOP delays discussed).
– CWIP-driven ROCE optics: while CWIP is real, the reliance on ratio normalization may mask operating margin risk if ramp underperforms.

Positive signals
– Detailed margin bridge with quantified drivers (fixed vs variable, FX impact, US tariff impact).
– Concrete operational milestones: Brazil dispatch start date; CVJ line utilization metrics; capex spend progress.
– Clear strategic direction: CVJ ramp + exports via group entities + Gujarat western-region plant.

7. Historical Comparison & Consistency Analysis (vs prior 3 calls provided)

a. Change in Tone Over Time

• Shift: More Optimistic vs earlier calls.
• What changed
• Q2 FY26 (Nov 2025): management expected improvement in 2H and called margin issues “temporary,” but tone acknowledged weaker first-half performance and delays.
• Q4 FY26 (May 2026): management highlights 2H EBITDA margin improvement to 8.48% and frames full-year margin decline as minor and driven by identifiable temporary factors.
• More confidence now in capacity utilization timeline (100% within 1.5 years) and export scaling (Brazil ramp).

b. Tracking Past Commitments vs Outcomes

• Past statement (Q2 FY26, Nov 2025): CAPEX completion expected by March ’27 (analyst asked for update; management discussed commissioning progress).
• Current call outcome: management confirms multiple lines operational and provides utilization status; still implies ramp to full utilization within 1.5 years (i.e., not fully “done” in March ’27 sense, but progress is evident).
• Flag: ✅/⏳ Partially delivered (commissioning progress delivered; full utilization still pending).
• Past statement (Q2 FY26): margin recovery expected as temporary factors improve.
• Current call: EBITDA improved in 2H but full-year EBITDA margin still slightly down; gross margin trend still a concern.
• Flag: ⏳ Delayed / not fully delivered (improvement, but not full recovery).
• Past statement (May 2025 Q4 FY25 call): expectation that new capacities would ramp and margins would normalize after one-offs.
• Current call: one-offs and mix/FX/tariff effects still present; margin recovery not fully achieved.
• Flag: ❌/⏳ Not fully delivered (narrative persists; recovery incomplete).

c. Narrative Shifts

• From “external uncontrollables” to “specific temporary drivers”:
• Earlier calls emphasized broad external pressures (exports, US, delays).
• Now management provides a more granular bridge (FX accounting, product mix impact, reciprocal tariff, trial power).
• CVJ emphasis strengthened:
• CVJ was discussed as a future growth lever earlier; now it’s central to revenue ramp and margin quality (“better than manual gear,” “100% localized,” market share target).
• Brazil moved from “expected” to “starting”:
• Earlier: Brazil order discussed as upcoming.
• Now: dispatch start and scaling volumes are concrete.

d. Consistency & Credibility Signals

• Medium credibility overall
• Credibility improved by correcting Toyota timing and providing operational utilization metrics.
• Credibility risk remains due to repeated “temporary” framing and refusal to provide firm revenue/margin commitments.
• CWIP-based ROCE explanation is consistent with prior discussions about capacity ramp and underutilization, but still defers accountability.

e. Evolution of Key Themes

• Demand / market: Improving (GST reform impact acknowledged; management sees optimism sustaining).
• Margins: Improved sequentially (2H EBITDA) but not structurally recovered (full-year still down; gross margin trend still declining).
• Expansion / capacity: Stronger execution narrative—more lines operational and utilization metrics shared.
• Exports: Moving from “potential” to “execution” (Brazil dispatch start; US tariff expectations; Honda recovery hopes).

f. Additional Insights (cross-period intelligence)

• Margin pressure appears to be shifting from “one-offs” to “structural mix + export tariff regime”:
• Even with better 2H EBITDA, full-year gross/EBITDA didn’t fully recover, suggesting mix and export economics may remain a recurring headwind.
• SOP delays remain a recurring theme (Maruti model SOP delays; export model launch timing), which increases execution risk to management’s utilization timeline.
• Management is increasingly using capacity utilization and CWIP optics to support ROCE and growth narratives—useful, but it raises the bar for actual margin expansion once utilization normalizes.